Mastocytosis, Systemic
Oncology·MeSH: Mastocytosis, Systemic
Prevalence
30.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| avapritinib | Blueprint Medicines Corp (BPMC) |
Frequently asked questions
How many drugs are in development for Mastocytosis, Systemic?
BioSniper tracks 1 drug in development for Mastocytosis, Systemic across 1 company.
How many clinical trials target Mastocytosis, Systemic?
There are 2 clinical trials targeting Mastocytosis, Systemic tracked by BioSniper.
What is the prevalence of Mastocytosis, Systemic?
The estimated prevalence of Mastocytosis, Systemic is approximately 30.0 per 100,000 population.
Deep-dive into Mastocytosis, Systemic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis